(PL 19611/0081), Ramipril 5mg Tablets (PL 19611/0082) and Ramipril 10mg Tablets (PL 19611/0083). These are prescription-only medicines to help lower blood pressure if too high (mild to moderate hypertension) and to prevent the heart getting weaker if you have recently suffered a heart attack. These can also be used to reduce the risk of heart attack, stroke, need for heart by-pass surgery in certain groups of patients over the age of 55 years, for example diabetics with additional risks of heart disease (high blood pressure, high cholesterol, smoking or previous heart condition). Ramipril Tablets contain the active ingredient ramipril, which acts to widen blood vessels, making it easier for the heart to pump blood through them and around th...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Updates of clinical guidelines and publication of new research results entail changes in our approac...
Currently, there are 10 angiotensin-converting enzyme(ACE) inhibitors available in the US. Captopril...
Ramipril is an anti-hypertensive drug, a category of ACE inhibitor that inhibit the actions of angio...
A clinical trial of 75 hypertensive subjects in stage II of the disease receiving ramipril monothera...
A clinical trial of 75 hypertensive subjects in stage II of the disease receiving ramipril monothera...
Ramipril is an anti-hypertensive drug, a category of ACE inhibitor that inhibit the actions of angio...
AH and diabetes mellitus are comorbid diseases and are interconnected by general pathophysiological ...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
The Heart Outcomes Prevention Evaluation (HOPE) study demonstrated that the angiotensin-converting e...
Background: Hypertension is one of the leading causes of the global burden of disease. Hypertension ...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Updates of clinical guidelines and publication of new research results entail changes in our approac...
Currently, there are 10 angiotensin-converting enzyme(ACE) inhibitors available in the US. Captopril...
Ramipril is an anti-hypertensive drug, a category of ACE inhibitor that inhibit the actions of angio...
A clinical trial of 75 hypertensive subjects in stage II of the disease receiving ramipril monothera...
A clinical trial of 75 hypertensive subjects in stage II of the disease receiving ramipril monothera...
Ramipril is an anti-hypertensive drug, a category of ACE inhibitor that inhibit the actions of angio...
AH and diabetes mellitus are comorbid diseases and are interconnected by general pathophysiological ...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
Ramipril and the development of diabetes.Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenb...
The Heart Outcomes Prevention Evaluation (HOPE) study demonstrated that the angiotensin-converting e...
Background: Hypertension is one of the leading causes of the global burden of disease. Hypertension ...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...
Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dy...